Samar Issa
0009-0008-2534-3428
Middlemore Hospital
30 papers found
Refreshing results…
TIDEL-Ii: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets
Acute Transient Global Ventricular Dysfunction As the Presenting Symptom of Anaplastic Large-Cell Lymphoma
Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study
Is rheumatoid arthritis a B-cell haematological disease with a predilection for the joints? Following the B cell thread to its logical conclusion
Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma
A case of refractory anemia with ring sideroblasts and associated thrombocytosis
Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation – an International Primary Central Nervous System Lymphoma Study Group project
Primary prophylaxis with granulocyte colony-stimulating factor (GCSF) reduces the incidence of febrile neutropenia in patients with non-Hodgkin lymphoma (NHL) receiving CHOP chemotherapy treatment without adversely affecting their quality of life: cost–benefit and quality of life analysis
Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI
Phase I Study of Intraventricular Administration of Rituximab in Patients With Recurrent CNS and Intraocular Lymphoma
Missing publications? Search for publications with a matching author name.